Hitherto, it remains totally unclear what causes these contrasting FOXO3 functions among different cancers, but the identification of FOXO3 modifications, co-factors and downstream targets involved in the control of different CSCs might provide informative clues. This evidence concerns the gene FOXO3 and cancer.